Page last updated: 2024-08-21

isoxazoles and 3,9-bis((ethylthio)methyl)-k-252a

isoxazoles has been researched along with 3,9-bis((ethylthio)methyl)-k-252a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murata, M1

Reviews

1 review(s) available for isoxazoles and 3,9-bis((ethylthio)methyl)-k-252a

ArticleYear
[Therapy of Parkinson's disease--up to date].
    Rinsho shinkeigaku = Clinical neurology, 2008, Volume: 48, Issue:11

    Topics: Anticonvulsants; Antiparkinson Agents; Carbazoles; Dopamine Agents; Dopamine Agonists; Drug Design; Genetic Therapy; Humans; Isoxazoles; Levodopa; Neuroprotective Agents; Parkinson Disease; Randomized Controlled Trials as Topic; Substantia Nigra; Zonisamide

2008